A clinical trial to evaluate whether a potential new drug is an effective and safe way to make damaged kidneys work better in patients with type II diabetes

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-021358-20

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To evaluate the efficacy of PF-00489791 in the reduction of albuminuria in subjects with type 2 diabetes and overt nephropathy.


Critère d'inclusion

  • Chronic kidney disease (CKD), also known as chronic renal disease